Foreign buyers snap up undervalued Australian small caps

A wave of foreign-led buyouts is sweeping through Australia’s small and mid-cap companies, driven by steeply discounted valuations and a glut of available capital among acquirers. This week, drug company Mayne Pharma (ASX:MYX) joined the rapidly expanding coterie of small to mid-sized companies on the receiving end of a takeover offer. Actually, the Adelaide-based institution made an encore appearance on the list, having been embroiled in a takeover drama with Cosette of the US for most of last year. With the shares marked down severely by last year’s fiasco, new suitor Gedeon Richter’s offer was at a meaty 100% premium.
Why now?
The surge in takeover activity contradicts the broader market narrative of an overvalued Australian stock exchange. Instead, foreign acquirers are zeroing in on smaller companies trading at their widest discount to large caps in at least two decades. According to Datt Capital’s chief investment officer, Emmanuel Datt, these firms now trade at roughly 14 times earnings, compared with 17-18 times for the largest stocks—a gap not seen since the early 2000s.
Historically, small-cap valuations have moved inversely with interest rates. “We think takeovers will continue,” Wilson Asset Management’s lead portfolio manager Oscar Oberg said recently. “The Australian market is very cheap in the space and offshore private equity buyers and trade buyers tend to be the smart money.”
One of the most striking examples is Mayne Pharma (ASX:MYX), which received a 100% premium takeover offer from Gedeon Richter this week. The Adelaide-based drug company had previously been the target of a failed bid from US firm Cosette last year, leaving its shares severely depressed.
Who’s buying—and who’s being left behind?
Foreign acquirers dominate the current wave, with deals spanning industries. Goldfields’ unsucceeded $38 billion bid for Northern Star Resources (ASX:NST) stands out as the largest in mining, while software group Nuix (ASX:NXL) is in advanced talks with US investor Haveli Investments for a $944 million deal at a 73% premium. Childcare operator G8 Education (ASX:GEM) is negotiating a $190 million buyout at a 160% premium, and waste management firm Cleanaway (ASX:CWY) accepted a $9.4 billion offer from Sweden’s EQT.
Not all targets are attracting bids. Companies like Steadfast (ASX:SDF), Ingenia Communities Group (ASX:INA), and Bluescope Steel (ASX:BSL) have received unrequited approaches.
Macquarie Equities has identified 16 industrial sector targets in its latest screening, focusing on stocks trading at least 30% below their three-year highs with a track record of profitability. Nearly half of the firms on its original 2020 list have since been involved in mergers or acquisitions, with two from last November’s update already under offer. The firm’s methodology suggests the current volatility is creating opportunities, though past predictions, like its calls on Transurban Group (ASX:TCL) and Aurizon Holdings (ASX:AZJ), have not always materialized.
What it means for investors
The list of potential targets includes firms like Australian Finance Group (ASX:AFG), ARB Corporation (ASX:ARB), and Domino’s Pizza Enterprises (ASX:DMP), all trading below historical peaks. Ramsay Healthcare (ASX:RHC), which survived a failed $20 billion bid in 2022, now operates at a higher valuation and could re-enter the spotlight if conditions align.